Anti-MOG encephalitis mimicking small vessel CNS vasculitis | Neurology Neuroimmunology & Neuroinflammation
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology
Recent developments in MOG-IgG associated neurological disorders - Harald Hegen, Markus Reindl, 2020
What is ANTI-MOG (MYELIN OLIGODENDROCYTE GLYCOPROTEIN) SERUM Test ?
Antibodies to myelin oligodendrocyte glycoprotein (MOG): Analysis of the impact of the glycosylation site of MOG for recognition
Anti-MOG autoantibody-associated schizophreniform psychosis | Acta Neuropsychiatrica | Cambridge Core
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology
MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder - ScienceDirect
What is MOGAD? | MOG Antibody Disease | SRNA
Table 1 from Defining distinct features of anti-MOG antibody associated central nervous system demyelination | Semantic Scholar
MOG Antibody (ABIN668481)
Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event | NEJM
Myelin oligodendrocyte glycoprotein antibody-associated disorders: clinical spectrum, diagnostic evaluation, and treatment options
Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases | Journal of Neuroinflammation | Full Text
Anti-MOG Antibody Test Identifies Atypical Features, Prognosis in MS - Neurology Advisor
Overlapping autoimmune syndrome: A case of concomitant anti-NMDAR encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease - ScienceDirect
Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis | PNAS
Frontiers | MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder
The spectrum of MOG autoantibody-associated demyelinating diseases | Nature Reviews Neurology
Selective Depletion of Antigen-Specific Antibodies for the Treatment of Demyelinating Disease - ScienceDirect
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Myelitis Presenting with Headache | Canadian Journal of Neurological Sciences | Cambridge Core
Exploring the Molecular Aspects of Glycosylation in MOG Antibody Disease (MOGAD) | Bentham Science
Defining distinct features of anti-MOG antibody associated central nervous system demyelination - Martin S. Weber, Tobias Derfuss, Imke Metz, Wolfgang Brück, 2018
Overview of patient cohort, antibody status, and anti-MOG antibody... | Download Scientific Diagram
JCI Insight - Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology
